Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
Epub 2013 Feb 11
which is the hormonally active form of vitamin D
¹⁶]hexadeca-1(15)
IACS-8968 is a dual IDO and TDO inhibitor
confirming the selectivity of the drug
(R)-Elagolix Size:Contact [email protected] for quotation Epub 2013 Feb 11Elagolix is a highly potent, selective, orally active, short duration, non peptide antagonist of the gonadotropin releasing hormone receptor (GnRHR) (KD = 54 pM). Target: GnRHin vitro: Elagolix is a short acting, nonpeptide, GnRH antagonist, administered orally, that unlike injectable depot GnRH agonists and antagonists, produces a dose dependent suppression of ovarian estrogen production, that is, from partial suppression at lower doses to full
US$ 36.38
US$ 30.00